Novartis AG - Depositary Receipt (Common Stock)
DE ˙ DB ˙ US66987V1098
121,00 € 0,00 (0,00%)
2026-06-04
AKTIENPREIS
SecurityDE:NOTA / Novartis AG - Depositary Receipt (Common Stock)
InstitutionFoster & Motley Inc
Latest Disclosed Ownership22,113 shares
Latest Disclosed Value $ 3,378
Foster & Motley Inc reports 0.26% increase in ownership of NOTA / Novartis AG - Depositary Receipt (Common Stock)

On April 21, 2026 - Foster & Motley Inc filed a 13F-HR form disclosing ownership of 22,113 shares of Novartis AG - Depositary Receipt (Common Stock) (DE:NOTA) valued at $2,841,520 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 15, 2026 disclosing 22,055 shares of Novartis AG - Depositary Receipt (Common Stock). This represents a change in shares of 0.26% during the quarter. The current value of the position is $2,675,673 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-21 2026-03-31 13F Novartis A G Spon Adr ADR 66987V109 22,113 58 0.26 3 0.00 0.1743
2026-01-15 2025-12-31 13F Novartis A G Spon Adr ADR 66987V109 22,055 2,279 11.52 3 50.00 0.1622
2025-10-23 2025-09-30 13F Novartis A G Spon Adr ADR 66987V109 19,776 -193 -0.97 3 0.00 0.1367
2025-07-29 2025-06-30 13F Novartis A G Spon Adr ADR 66987V109 19,969 1,030 5.44 2 0.00 0.1396
2025-05-08 2025-03-31 13F Novartis A G Spon Adr ADR 66987V109 18,939 222 1.19 2 100.00 0.1329
2025-01-23 2024-12-31 13F Novartis A G Spon Adr ADR 66987V109 18,717 -221 -1.17 2 -50.00 0.1184
2024-10-30 2024-09-30 13F Novartis A G Spon Adr ADR 66987V109 18,938 2,800 17.35 2 100.00 0.1381
2024-08-02 2024-06-30 13F Novartis A G Spon Adr ADR 66987V109 16,138 3,580 28.51 2 0.00 0.1181
2024-04-18 2024-03-31 13F Novartis A G Spon Adr ADR 66987V109 12,558 3,110 32.92 1 0.0836
2024-02-01 2023-12-31 13F Novartis A G Spon Adr ADR 66987V109 9,448 4,358 85.62 1 0.0709
2023-10-24 2023-09-30 13F Novartis A G Spon Adr ADR 66987V109 5,090 1,467 40.49 1 0.0425
2023-08-08 2023-06-30 13F Novartis A G Spon Adr ADR 66987V109 3,623 0 0.00 0 0.0283
2023-05-09 2023-03-31 13F Novartis A G Spon Adr ADR 66987V109 3,623 -52 -1.41 0 0.0271
2023-02-09 2022-12-31 13F Novartis A G Spon Adr ADR 66987V109 3,675 450 13.95 0 -100.00 0.0284
2022-11-04 2022-09-30 13F Novartis A G Spon Adr ADR 66987V109 3,225 -180 -5.29 245 -14.93 0.0233
2022-08-09 2022-06-30 13F Novartis A G Spon Adr ADR 66987V109 3,405 0 0.00 288 -3.68 0.0253
2022-04-28 2022-03-31 13F Novartis A G Spon Adr ADR 66987V109 3,405 -799 -19.01 299 -18.75 0.0234
2022-01-25 2021-12-31 13F Novartis A G Spon Adr ADR 66987V109 4,204 -2,650 -38.66 368 -34.40 0.0286
2021-10-29 2021-09-30 13F Novartis A G Spon Adr ADR 66987V109 6,854 813 13.46 561 1.81 0.0467
2021-07-20 2021-06-30 13F Novartis A G Spon Adr ADR 66987V109 6,041 -318 -5.00 551 1.29 0.0461
2021-04-26 2021-03-31 13F Novartis A G Spon Adr ADR 66987V109 6,359 6,359 544 0.0454
2016-04-20 2016-03-31 13F Novartis A G Spon Adr ADR 66987V109 0 0 0 0.0000
2015-11-09 2015-09-30 13F Novartis A G Spon Adr ADR 66987V109 0 0 0 0.0000
2015-08-10 2015-06-30 13F Novartis A G Spon Adr ADR 66987V109 0 -2,215 -100.00 0 -100.00
2015-04-16 2015-03-31 13F Novartis A G Spon Adr ADR 66987V109 2,215 0 0.00 218 6.34 0.0479
2015-01-22 2014-12-31 13F Novartis A G Spon Adr ADR 66987V109 2,215 85 3.99 205 2.50 0.0464
2014-10-16 2014-09-30 13F Novartis A G Spon Adr ADR 66987V109 2,130 -80 -3.62 200 0.00 0.0464
2014-07-25 2014-06-30 13F Novartis A G Spon Adr ADR 66987V109 2,210 2,210 200 0.0462
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.